X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-03-10 | MYOV | Sumitomo Chemical Co., Ltd. | 10% | P - Purchase | $27.00 | +51,599,200 | 45,798,176 | -889% | +$1,393,178,400 | ||||||
2023-01-18 | MYOV | Lang Matthew | GC, Corp. Secy. | S - Sale | $26.89 | -1,272 | 354,303 | 0% | -$34,204 | ||||||
2023-01-18 | MYOV | Merendino Lauren | Chief Commercial Officer | S - Sale | $26.89 | -2,008 | 169,538 | -1% | -$53,995 | ||||||
2023-01-18 | MYOV | Marek David C | Principal Exec Officer | S - Sale | $26.89 | -8,037 | 417,599 | -2% | -$216,115 | ||||||
2023-01-18 | MYOV | Arjona Ferreira Juan Camilo | Chief Medical Officer | S - Sale | $26.89 | -1,109 | 246,684 | 0% | -$29,821 | ||||||
2023-01-04 | MYOV | Arjona Ferreira Juan Camilo | Chief Medical Officer | S - Sale | $26.90 | -2,251 | 247,793 | -1% | -$60,552 | ||||||
2023-01-04 | MYOV | Lang Matthew | GC, Corp. Secy. | S - Sale | $26.90 | -2,779 | 355,575 | -1% | -$74,755 | ||||||
2022-12-16 | MYOV | Mehra Uneek | Principal Financial Officer | S - Sale | $26.75 | -2,241 | 202,696 | -1% | -$59,947 | ||||||
2022-10-18 | MYOV | Merendino Lauren | Chief Commercial Officer | S - Sale | $25.20 | -1,703 | 171,546 | -1% | -$42,916 | ||||||
2022-10-18 | MYOV | Marek David C | Principal Exec Officer | S - Sale | $25.20 | -11,156 | 425,636 | -3% | -$281,131 | ||||||
2022-10-18 | MYOV | Lang Matthew | GC, Corp. Secy. | S - Sale | $25.20 | -1,933 | 358,354 | -1% | -$48,712 | ||||||
2022-10-18 | MYOV | Arjona Ferreira Juan Camilo | Chief Medical Officer | S - Sale | $25.20 | -1,604 | 250,044 | -1% | -$40,421 | ||||||
2022-10-04 | MYOV | Arjona Ferreira Juan Camilo | Chief Medical Officer | S - Sale | $24.40 | -2,738 | 251,648 | -1% | -$66,807 | ||||||
2022-10-04 | MYOV | Lang Matthew | GC, Corp. Secy. | S - Sale | $24.40 | -3,679 | 360,287 | -1% | -$89,768 | ||||||
2022-09-16 | MYOV | Mehra Uneek | Principal Financial Officer | S - Sale | $18.86 | -9,243 | 204,937 | -4% | -$174,323 | ||||||
2022-08-15 | MYOV | Lang Matthew | GC, Corp. Secy. | S - Sale | $18.23 | -31,214 | 363,966 | -8% | -$569,031 | ||||||
2022-07-18 | MYOV | Lang Matthew | GC, Corp. Secy. | S - Sale | $12.87 | -1,935 | 270,400 | -1% | -$24,903 | ||||||
2022-07-18 | MYOV | Merendino Lauren | Chief Commercial Officer | S - Sale | $12.87 | -1,704 | 173,249 | -1% | -$21,930 | ||||||
2022-07-18 | MYOV | Marek David C | Principal Exec Officer | S - Sale | $12.87 | -11,164 | 436,792 | -2% | -$143,681 | ||||||
2022-07-18 | MYOV | Arjona Ferreira Juan Camilo | Chief Medical Officer | S - Sale | $12.87 | -1,606 | 254,386 | -1% | -$20,669 | ||||||
2022-07-06 | MYOV | Arjona Ferreira Juan Camilo | Chief Medical Officer | S - Sale | $13.40 | -2,755 | 255,992 | -1% | -$36,917 | ||||||
2022-07-06 | MYOV | Lang Matthew | GC, Corp. Secy. | S - Sale | $13.40 | -3,702 | 272,335 | -1% | -$49,607 | ||||||
2022-05-27 | MYOV | Arjona Ferreira Juan Camilo | Chief Medical Officer | S - Sale | $10.07 | -1,382 | 258,747 | -1% | -$13,917 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |